使用孕激素预防单子早产的挑战:当前知识和临床建议
David B Nelson1, Yevgenia Y Fomina1
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
17α-hydroxyprogesterone caproate (17OHP-C) 已不再被FDA批准用于预防重复的早产. 这一决定给自发早产预防的治疗选择留下了空白.
科学领域:
- 产科和妇科 产科和妇科
- 围产儿医学 围产儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过早出生是全球婴儿死亡的主要原因之一.
- 孕激素治疗预防早产是有争议的.
- 17-α-hydroxyprogesterone caproate (17OHP-C) 是一种合成的孕激素,以前用于预防重复的早产.
研究的目的:
- 审查17OHP-C用于预防早产的历史背景.
- 分析支持孕激素疗效的数据的挑战和局限性.
- 讨论未来影响早产率的方向.
主要方法:
- 对前列腺激素治疗现有文献和临床试验数据的审查.
- 对有关17OHP-C.的FDA决定和监管行动的分析.
- 综合有关不同孕激素配方和患者群体的证据.
主要成果:
- 美国FDA已经撤销了17OHP-C的加速批准.
- 目前没有FDA批准的自发早产预防治疗方法.
- 支持孕激素使用的证据因配方和研究人口而异.
结论:
- 17OHP-C的撤回凸显了早产预防的复杂性和争议性.
- 需要进一步的研究来确定有效和安全的干预措施.
- 解决早产需要一个多方面的方法,超越目前的孕激素疗法.
更多相关视频
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
相关概念视频
Birth Control Methods
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
